Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
Submitted by
admin
on August 17, 2018 - 9:34am
Source:
CP Wire
News Tags:
XERIS
diabetes
artificial pancreas
devices
clinical trials
Headline:
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
snippet:
Current dry-powder glucagon formulations must be used immediately because they begin to degrade after reconstitution
Xeris’ ready-to-use liquid glucagon is room-temperature stable over extended periods of time
The ability to deliver both insulin and glucagon may reduce the risk of hypoglycemia by mirroring the body’s normal glucose control,
Do Not Allow Advertisers to Use My Personal information
